Y. AYDINOK Et Al. , "Deferasirox Deferoxamine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload HYPERION," ASH , San Diego, United States Of America, 2013
AYDINOK, Y. Et Al. 2013. Deferasirox Deferoxamine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload HYPERION. ASH , (San Diego, United States Of America).
AYDINOK, Y., Kattamis, A., Cappellini, D., ElBeshlawy, A., Origa, R., Elalfy, M., ... Kılınç, Y.(2013). Deferasirox Deferoxamine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload HYPERION . ASH, San Diego, United States Of America
AYDINOK, YEŞİM Et Al. "Deferasirox Deferoxamine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload HYPERION," ASH, San Diego, United States Of America, 2013
AYDINOK, YEŞİM Et Al. "Deferasirox Deferoxamine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload HYPERION." ASH , San Diego, United States Of America, 2013
AYDINOK, Y. Et Al. (2013) . "Deferasirox Deferoxamine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload HYPERION." ASH , San Diego, United States Of America.
@conferencepaper{conferencepaper, author={YEŞİM AYDINOK Et Al. }, title={Deferasirox Deferoxamine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload HYPERION}, congress name={ASH}, city={San Diego}, country={United States Of America}, year={2013}}